Mean tumor weights in MB49-inoculated STING−/− mice were 0.7 g at following BCG-disA-OE treatment (not significantly different from untreated WT or untreated STING−/− mice) whereas it was 0.2 g in treated WT mice (P = 0.02) (Fig. S15b) and this was associated with an overall reduction of immune (CD45+) cells infiltrating tumors in STING−/− mice as compared with WT mice (Fig. S15c). Here, PTPRC is linked to neoplasm.